Targeting KRAS Mutations Beyond G12C: Advancing ACBI3 for Comprehensive KRAS Degradation and Tumour Regression

Time: 1:45 pm
day: Day 1, Track 2, PM

Speakers:

Andreas MANTOULIDIS